Top Key Companies for Cancer Early Detection and Diagnosis Market: Exact Sciences, Grail, Genetron Health, New Horizon Health, Burning Rock, Berry Oncology, Shanghai Kunyuan Biotechnology, Oncognostic, Epigenomics, Abbott, Qiagen, iStat Biomedical.
Global Cancer Early Detection and Diagnosis Market Size was estimated at USD 422.86 million in 2022 and is projected to reach USD 488.1 million by 2028, exhibiting a CAGR of 2.42% during the forecast period.
Global Cancer Early Detection and Diagnosis Market Overview And Scope:
The Global Cancer Early Detection and Diagnosis Market Report 2025 provides comprehensive analysis of market development components, patterns, flows, and sizes. This research study of Cancer Early Detection and Diagnosis utilized both primary and secondary data sources to calculate present and past market values to forecast potential market management for the forecast period between 2025 and 2032. It includes the study of a wide range of industry parameters, including government policies, market environments, competitive landscape, historical data, current market trends, technological innovations, upcoming technologies, and technological progress within related industries. Additionally, the report provides an in-depth analysis of the value chain and supply chain to demonstrate how value is added at every stage in the product lifecycle. The study incorporates market dynamics such as drivers, restraints/challenges, trends, and their impact on the market.
This Market Research Report provides a comprehensive analysis of the global Cancer Early Detection and Diagnosis Market and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cancer Early Detection and Diagnosis portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Cancer Early Detection and Diagnosis market.
Global Cancer Early Detection and Diagnosis Market Segmentation
By Type, Cancer Early Detection and Diagnosis market has been segmented into:
Colorectal Cancer
Liver Cancer
Lung Cancer
Other
By Application, Cancer Early Detection and Diagnosis market has been segmented into:
Hospital
Medical Center
Other
Regional Analysis of Cancer Early Detection and Diagnosis Market:
North America (U.S., Canada, Mexico)
Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
Competitive Landscape of Cancer Early Detection and Diagnosis Market:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Cancer Early Detection and Diagnosis market study focused on including all the primary level, secondary level and tertiary level competitors in the report.The data generated by conducting the primary and secondary research. The report covers detail analysis of driver, constraints and scope for new players entering the Cancer Early Detection and Diagnosis market.
Top Key Companies Covered in Cancer Early Detection and Diagnosis market are:
Exact Sciences
Grail
Genetron Health
New Horizon Health
Burning Rock
Berry Oncology
Shanghai Kunyuan Biotechnology
Oncognostic
Epigenomics
Abbott
Qiagen
iStat Biomedical
Chapter 1: Introduction
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
Chapter 2:Executive Summary
Chapter 3:Growth Opportunities By Segment
3.1 By Type
3.2 By Application
Chapter 4: Market Landscape
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
Chapter 5: Cancer Early Detection and Diagnosis Market by Type
5.1 Cancer Early Detection and Diagnosis Market Overview Snapshot and Growth Engine
5.2 Cancer Early Detection and Diagnosis Market Overview
5.3 Colorectal Cancer
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Colorectal Cancer: Geographic Segmentation
5.4 Liver Cancer
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Liver Cancer: Geographic Segmentation
5.5 Lung Cancer
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size (2017-2032F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Lung Cancer: Geographic Segmentation
5.6 Other
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size (2017-2032F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 Other: Geographic Segmentation
Chapter 6: Cancer Early Detection and Diagnosis Market by Application
6.1 Cancer Early Detection and Diagnosis Market Overview Snapshot and Growth Engine
6.2 Cancer Early Detection and Diagnosis Market Overview
6.3 Hospital
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2017-2032F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Hospital: Geographic Segmentation
6.4 Medical Center
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2017-2032F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Medical Center: Geographic Segmentation
6.5 Other
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size (2017-2032F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Other: Geographic Segmentation
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 Cancer Early Detection and Diagnosis Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Cancer Early Detection and Diagnosis Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 Cancer Early Detection and Diagnosis Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 EXACT SCIENCES
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 GRAIL
7.4 GENETRON HEALTH
7.5 NEW HORIZON HEALTH
7.6 BURNING ROCK
7.7 BERRY ONCOLOGY
7.8 SHANGHAI KUNYUAN BIOTECHNOLOGY
7.9 ONCOGNOSTIC
7.10 EPIGENOMICS
7.11 ABBOTT
7.12 QIAGEN
7.13 ISTAT BIOMEDICAL
Chapter 8: Global Cancer Early Detection and Diagnosis Market Analysis, Insights and Forecast, 2017-2032
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 Colorectal Cancer
8.2.2 Liver Cancer
8.2.3 Lung Cancer
8.2.4 Other
8.3 Historic and Forecasted Market Size By Application
8.3.1 Hospital
8.3.2 Medical Center
8.3.3 Other
Chapter 9: North America Cancer Early Detection and Diagnosis Market Analysis, Insights and Forecast, 2017-2032
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 Colorectal Cancer
9.4.2 Liver Cancer
9.4.3 Lung Cancer
9.4.4 Other
9.5 Historic and Forecasted Market Size By Application
9.5.1 Hospital
9.5.2 Medical Center
9.5.3 Other
9.6 Historic and Forecast Market Size by Country
9.6.1 US
9.6.2 Canada
9.6.3 Mexico
Chapter 10: Eastern Europe Cancer Early Detection and Diagnosis Market Analysis, Insights and Forecast, 2017-2032
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 Colorectal Cancer
10.4.2 Liver Cancer
10.4.3 Lung Cancer
10.4.4 Other
10.5 Historic and Forecasted Market Size By Application
10.5.1 Hospital
10.5.2 Medical Center
10.5.3 Other
10.6 Historic and Forecast Market Size by Country
10.6.1 Bulgaria
10.6.2 The Czech Republic
10.6.3 Hungary
10.6.4 Poland
10.6.5 Romania
10.6.6 Rest of Eastern Europe
Chapter 11: Western Europe Cancer Early Detection and Diagnosis Market Analysis, Insights and Forecast, 2017-2032
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 Colorectal Cancer
11.4.2 Liver Cancer
11.4.3 Lung Cancer
11.4.4 Other
11.5 Historic and Forecasted Market Size By Application
11.5.1 Hospital
11.5.2 Medical Center
11.5.3 Other
11.6 Historic and Forecast Market Size by Country
11.6.1 Germany
11.6.2 UK
11.6.3 France
11.6.4 Netherlands
11.6.5 Italy
11.6.6 Russia
11.6.7 Spain
11.6.8 Rest of Western Europe
Chapter 12: Asia Pacific Cancer Early Detection and Diagnosis Market Analysis, Insights and Forecast, 2017-2032
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 Colorectal Cancer
12.4.2 Liver Cancer
12.4.3 Lung Cancer
12.4.4 Other
12.5 Historic and Forecasted Market Size By Application
12.5.1 Hospital
12.5.2 Medical Center
12.5.3 Other
12.6 Historic and Forecast Market Size by Country
12.6.1 China
12.6.2 India
12.6.3 Japan
12.6.4 South Korea
12.6.5 Malaysia
12.6.6 Thailand
12.6.7 Vietnam
12.6.8 The Philippines
12.6.9 Australia
12.6.10 New Zealand
12.6.11 Rest of APAC
Chapter 13: Middle East & Africa Cancer Early Detection and Diagnosis Market Analysis, Insights and Forecast, 2017-2032
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 Colorectal Cancer
13.4.2 Liver Cancer
13.4.3 Lung Cancer
13.4.4 Other
13.5 Historic and Forecasted Market Size By Application
13.5.1 Hospital
13.5.2 Medical Center
13.5.3 Other
13.6 Historic and Forecast Market Size by Country
13.6.1 Turkey
13.6.2 Bahrain
13.6.3 Kuwait
13.6.4 Saudi Arabia
13.6.5 Qatar
13.6.6 UAE
13.6.7 Israel
13.6.8 South Africa
Chapter 14: South America Cancer Early Detection and Diagnosis Market Analysis, Insights and Forecast, 2017-2032
14.1 Key Market Trends, Growth Factors and Opportunities
14.2 Impact of Covid-19
14.3 Key Players
14.4 Key Market Trends, Growth Factors and Opportunities
14.4 Historic and Forecasted Market Size By Type
14.4.1 Colorectal Cancer
14.4.2 Liver Cancer
14.4.3 Lung Cancer
14.4.4 Other
14.5 Historic and Forecasted Market Size By Application
14.5.1 Hospital
14.5.2 Medical Center
14.5.3 Other
14.6 Historic and Forecast Market Size by Country
14.6.1 Brazil
14.6.2 Argentina
14.6.3 Rest of SA
Chapter 15 Investment Analysis
Chapter 16 Analyst Viewpoint and Conclusion
Cancer Early Detection and Diagnosis Scope:
|
Report Data
|
Cancer Early Detection and Diagnosis Market
|
|
Cancer Early Detection and Diagnosis Market Size in 2025
|
USD XX million
|
|
Cancer Early Detection and Diagnosis CAGR 2025 - 2032
|
XX%
|
|
Cancer Early Detection and Diagnosis Base Year
|
2024
|
|
Cancer Early Detection and Diagnosis Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Exact Sciences, Grail, Genetron Health, New Horizon Health, Burning Rock, Berry Oncology, Shanghai Kunyuan Biotechnology, Oncognostic, Epigenomics, Abbott, Qiagen, iStat Biomedical.
|
|
Key Segments
|
By Type
Colorectal Cancer
Liver Cancer
Lung Cancer
Other
By Applications
Hospital
Medical Center
Other
|
